{
    "id": 351785,
    "brand": "frau-pharma-neuropeak",
    "name": "Frau Pharma Fenfluramine",
    "slug": "frau-pharma-fenfluramine",
    "description": "Frau Pharma Fenfluramine is developed initially to treat obesity, Fenfluramine is currently undergoing Phase III clinical trials as an anticonvulsant agent to treat refractory generalized tonic-clonic seizures in Dravet syndrome.",
    "company_name": "Frau Pharma",
    "company_slug": "frau-pharma",
    "logo_url": "https://media.knowde.com/image/upload/f_auto,q_auto,w_128/v1708685337/production/Company/38029/logo/image",
    "banner_url": "https://media.knowde.com/image/upload/v1625607009/production/CategoryImage/509/category_image/FoodNutrition_10.jpg",
    "properties": {
        "Applications": [
            "Nutraceuticals & Supplements",
            "Nutrition & Well Being"
        ],
        "Product Families": [
            "Active Pharmaceutical Ingredients (APIs)",
            "Pharmaceutical Actives & Precursors"
        ]
    },
    "summary": {
        "Functions": [
            "Supplement",
            "Anti-Convulsant",
            "Dietary Supplement"
        ]
    }
}